A single-arm, open-label, phase 2 study evaluating pacritinib for patients with biochemical recurrence after definitive treatment for prostate cancer: Blast study.

被引：0
|
作者：
Kilari, Deepak
Szabo, Aniko
Hall, William A.
Nelson, Ariel Ann
Johnson, Scott
Giever, Thomas A.
Burfeind, John
Tolat, Parag
Bylow, Kathryn A.
Iczkowski, Kenneth
Sun, Yunguang
Rui, Hallgeir
Thomas, James P.
Nevalainen, Marja
机构：
[1] Med Coll Wisconsin, Froedtert Canc Ctr, Dept Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.TPS220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS220
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Anlotinib plus pemetrexed in patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study
    Chen, J.
    Wei, W.
    Zheng, L.
    Li, H.
    Feng, Y.
    Wan, T.
    Huang, Q.
    Liu, G.
    Tu, H.
    Qiu, J.
    Jiang, X.
    Xiong, Y.
    Zheng, M.
    Li, J.
    Huang, H.
    Song, L.
    Liu, J.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S734 - S734
  • [32] Apatinib for patients (pts) with advanced soft tissue sarcoma (STS) after chemotherapy: A prospective, open-label, single-arm, multicentered study.
    Hu, Haiyan
    Yao, Yang
    Fan, Zhengfu
    Zhang, Hongmei
    Chen, Jing
    Zhang, Xing
    Chen, Yong
    Qu, Guofan
    Huang, Gang
    Zhou, Yuhong
    Yu, Wenxi
    Wang, Xiaowen
    Zhuang, Rongyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study
    Mao, Lili
    Dai, Jie
    Bai, Xue
    Kong, Yan
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Duan, Rong
    Xu, Huayan
    Guo, Jun
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Anlotinib plus tislelizumab combined with chemotherapy as neoadjuvant treatment in triple-negative breast cancer: A prospective, single-arm, open-label phase II study.
    Luo, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Open-Label, Single-Arm, Phase II Study of Everolimus in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Graham, Anne
    Ramchandren, Radhakrishnan
    BLOOD, 2011, 118 (21) : 1169 - 1169
  • [36] Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
    Kawamura, Kentaro
    Fukumura, Shinobu
    Nikaido, Koki
    Tachi, Nobutada
    Kozuka, Naoki
    Seino, Tsugumi
    Hatakeyama, Kingya
    Mori, Mitsuru
    Ito, Yoichi M.
    Takami, Akiyoshi
    Hinotsu, Shiro
    Kuno, Atsushi
    Kawasaki, Yukihiko
    Horio, Yoshiyuki
    Tsutsumi, Hiroyuki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients
    Tomita, Yoshihiko
    Tatsugami, Katsunori
    Nakaigawa, Noboru
    Osawa, Takahiro
    Oya, Mototsugu
    Kanayama, Hiroomi
    Kondoh, Chihiro Nakayama
    Sassa, Naoto
    Nishimura, Kazuo
    Nozawa, Masahiro
    Masumori, Naoya
    Miyoshi, Yasuhide
    Kuroda, Shingo
    Tanaka, Shingo
    Kimura, Akiko
    Tamada, Satoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (11) : 952 - 959
  • [38] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Lin, Shi-Ming
    Lu, Sheng-Nan
    Chen, Ping-Tsung
    Jeng, Long-Bin
    Chen, Shinn-Cherng
    Hu, Chi-Tan
    Yang, Sien-Sing
    Le Berre, Marie-Aude
    Liu, Xuan
    Mitchell, David Y.
    Prins, Klaas
    Grevel, Joachim
    Pena, Carol A. E.
    Meinhardt, Gerold
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 199 - 208
  • [39] Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
    Kentaro Kawamura
    Shinobu Fukumura
    Koki Nikaido
    Nobutada Tachi
    Naoki Kozuka
    Tsugumi Seino
    Kingya Hatakeyama
    Mitsuru Mori
    Yoichi M. Ito
    Akiyoshi Takami
    Shiro Hinotsu
    Atsushi Kuno
    Yukihiko Kawasaki
    Yoshiyuki Horio
    Hiroyuki Tsutsumi
    Scientific Reports, 10
  • [40] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Shi-Ming Lin
    Sheng-Nan Lu
    Ping-Tsung Chen
    Long-Bin Jeng
    Shinn-Cherng Chen
    Chi-Tan Hu
    Sien-Sing Yang
    Marie-Aude Le Berre
    Xuan Liu
    David Y. Mitchell
    Klaas Prins
    Joachim Grevel
    Carol A. E. Peña
    Gerold Meinhardt
    Hepatology International, 2017, 11 : 199 - 208
12345